Abstract
Background
Mitochondrial impairments due to free radicals are implicated in a wide range of neurotoxicological alterations. Curcumin, an active ingredient of turmeric has shown protective efficacy against oxidative damage due to its strong antioxidant potential, but its efficiency is restricted due to low bioavailability in the mitochondria. In view of this, we have synthesized mitochondria-targeted curcumin (MTC) with an aim to investigate its efficacy against rotenone-induced oxidative damage in mice and isolated mitochondria.
Methods
MTC was synthesized by attaching the triphenylphosphonium cation (TPP) as a cationic carrier to the curcumin to assess its protective efficacy in rotenone-induced in-vitro and in-vivo toxicity in mice.
Results
In-vitro treatment of rotenone in isolated mitochondria caused a significant increase in lipid peroxidation (2.74 fold, 3.62 fold), protein carbonyl contents (2.62 fold, 1.81 fold), and decrease in levels of reduced glutathione (2.02 fold, 1.70 fold) as compared to control. Pre-treatment of curcumin and MTC along with rotenone in the isolated mitochondria significantly reduce the oxidative stress as compared to those treated with rotenone alone. Rotenone treatment in mice significantly increased lipid peroxidation (2.02 fold) and decreased the levels of reduced glutathione (2.99 fold), superoxide dismutase (2.09 fold) and catalase (3.60 fold) in the liver as compared to controls. Co-treatment of curcumin and MTC along with rotenone significantly reduced lipid peroxidation (1.26 fold, 1.76 fold) and increased the levels of reduced glutathione (1.60 fold, 2.43 fold), superoxide dismutase (1.45 fold, 1.99 fold) and catalase (2.32 fold, 2.90 fold) as compared to those treated with rotenone alone.
Conclusion
The results of the present study indicate that the protective efficacy of MTC against rotenone-induced oxidative damage was more promising than curcumin in both in-vitro and in-vivo system which indicates the enhanced bioavailability of MTC.
Similar content being viewed by others
References
Wanders RJ, Ruiter JP, IJLst L, Waterham HR, Houten SM. The enzymology of mitochondrial fatty acid beta-oxidation and its application to follow-up analysis of positive neonatal screening results. J Inherit Metab. 2010;33:479–94.
Contreras L, Drago I, Zampese E, Pozzan T. Mitochondria: the calcium connection. Biochim Biophys Acta. 2010;1797:607–18.
Ahn CS, Metallo CM. Mitochondria as biosynthetic factories for cancer proliferation. Cancer Metab. 2015;3(1):1.
Jimenez JJ, Bernal JL, Nozal MJ. Determination of rotenone residues in raw honey by solid-phase extraction and high-performance liquid chromatography. J Chromatogr. A. 2000;A871:67–73.
Talpade DJ, Greene JG, Higgins DS Jr, Greenamyre JT. In-vivo labeling of mitochondrial complex I (NADH: ubiquinoneoxidoreductase) in rat brain using [(3)H]dihydrorotenone. J Neurochem. 200(75):2611–21.
Yong R, Liu RW, Jiang H, Jiang Q, Feng J. Selective vulnerability of dopaminergic neurons to microtubule depolymerization. J Biol Chem. 2005;280:34105–12.
Nehru B, Verma R, Khanna P, Sharma SK. Behavioral alterations in rotenone model of Parkinson’s disease: attenuation by co-treatment of centrophenoxine. Brain Res. 2008;1201:122–7.
Jastroch M, Divakaruni AS, Mookerjee S, Treberg JR, Brand MD. Mitochondrial proton and electron leaks. Essays Biochem. 2010;47:53–67.
Liu Y, Fiskum G, Schubert D. Generation of reactive oxygen species by the mitochondria electron transport chain. J Neurochem. 2002;80:780–7.
Im AR, Kim YH, Uddin MR, Chae S, Lee HW, Kim YH, et al. Betaine protects against rotenone-induced neurotoxicity in PC12 cells. Cell Mol Neurobiol. 2013;33(5):625–35.
Samantaray S, Knaryan VH, Guyton MK, Matzelle DD, Ray SK, Banik NL. The parkinsonian neurotoxin rotenone activates calpain and caspase-3 leading to motoneuron degeneration in spinal cord of Lewis rats. Neuroscience. 2007;146(2):741–55.
Newhouse K, Hsuan SL, Chang SH, Cai B, Wang Y, Xia Z. Rotenone-induced apoptosis is mediated by p38 and jnk map kinases in human dopaminergic SH-SY5Y cells. Toxicol Sci. 2004;79:137–46.
Xu Y, Liu C, Chen S, Ye Y, Guo M, Ren Q, et al. Activation of AMPK and inactivation of Akt result in suppression of mTOR-mediated S6K1 and 4E-BP1 pathways leading to neuronal cell death in in-vitro models of Parkinson's disease. Cell Signal. 2014;26(8):1680–9.
Zhou Q, Liu C, Liu W, Zhang H, Zhang R, Liu J, et al. Rotenone induction of hydrogen peroxide inhibits mTOR-mediated S6K1 and 4E-BP1/eIF4E pathways, leading to neuronal apoptosis. Toxicol Sci. 2015;143(1):81–96.
Yadav RS, Sankhwar ML, Shukla RK, Chandra R, Pant AB, Islam F, et al. Attenuation of arsenic neurotoxicity by curcumin in rats. Toxicol Appl Pharmacol. 2009;240:367–76.
Yadav RS, Chandravanshi LP, Shukla RK, Sankhwar ML, Ansari RW, Shukla PK, et al. Neuroprotective efficacy of curcumin in arsenic induced cholinergic dysfunctions in rats. Neurotoxicology. 2011;32:760–8.
Srivastava P, Yadav RS, Chandravanshi LP, Shukla RK, Dhuriya YK, Chauhan LK, et al. Unraveling the mechanism of neuroprotection of curcumin in arsenic induced cholinergic dysfunctions in rats. Toxicol Appl Pharmacol. 2014;15:428–40.
Lin J, Shih CA. Inhibitory effect of curcumin on xanthine dehydrogenase/oxidase induced by phorbol-12-myristate-13-acetate in NIH3T3 cells. Carcinogenesis. 1994;15:1717–21.
Lenaz G, Fato R, Genova ML, Bergamini C, Bianchi C, Biondi A, et al. Structural and functional aspects. Biochimica. Et. Biophysica.Acta. 2006;1757:1406–20.
Trnka J, Elkalaf M, Anděl M. Lipophilic triphenylphosphoniumcations inhibit mitochondrial electron transport chain and induce mitochondrial proton leak. PLoS One. 2015;10(4).
Chen Q, Vazquez EJ, Moghaddas S, Hoppel CL, Lesnefsky EJ. Production of reactive oxygen species by mitochondria. J Biol Chem. 2003;278:36027–31.
Murphy MP. Targeting lipophilic cations to mitochondria. Biochim Biophys Acta. 2008;1777:1028–31.
Krishna Mohan PR, Sreelakshmi G, Muraleedharan CV, Joseph R. Water soluble complexes of curcumin with cyclodextrins: characterization by FT-Raman spectroscopy. Vib Spectrosc. 2012;62:77–84.
Reddy CA, Somepalli V, Golakoti T, Kanugula AK, Karnewar S, Rajendiran K, et al. Mitochondrial-targeted curcuminoids: a strategy to enhance bioavailability and anticancer efficacy of curcumin. PLoS One. 2014;9(3):e89351.
Jat D, Parihar P, Kothari SC, Parihar MS. Curcumin reduces oxidative damage by increasing reduced glutathione and preventing membrane permeability transition in isolated brain mitochondria. Cell Mol Biol. 2013;59:OL1899–905.
Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95:351–8.
Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 1990;186:464–78.
Hasan M, Haider SS. Acetyl homocysteinthiolactone protect against some neurotoxic effects of thallium. Neurotoxicology. 1989;10:257–62.
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193(1):265–75.
Reddy AC, Lokesh BR. Effect of dietary turmeric (Curcuma longa) on iron-induced lipid peroxidation in the rat liver. Food Chem Toxicol. 1994;32:279–83.
Zhu YG, Chen XC, Chen ZZ, Zeng YQ, Sh GB, Su YH, et al. Curcumin protects mitochondria from oxidative damage and attenuates apoptosis in cortical neurons. Acta Pharmacol Sin. 2004;25:1606–12.
Smith R, Porteous CM, Gane AM, Michael MP. Delivery of bioactive molecules to mitochondria in-vivo. Proc Natl Acad Sci U S A. 2003;100(9):5407–12.
Azzone GF, Pietrobon D, Zoratti M. Determination of the proton electrochemical gradient across biological membranes. Curr Top Bioenerg. 1984;13:1–77.
Brand MD, Brown GC, Cooper CE. Measurement of mitochondrial proton motive force. IRL Press. Oxford. UK . 1995; 4: 39–62.
Hu Q, Ren J, Li G, Wu J, Wu X, Wang G, et al. The mitochondrially targeted antioxidant MitoQ protects the intestinal barrier by ameliorating mitochondrial DNA damage via the Nrf2/ARE signaling pathway. Cell Death Dis. 2018;9(3):403.
Hughes G, Murphy MP, Ledgerwood EC. Mitochondrial reactive oxygen species regulate the temporal activation of nuclear factor NF-kappaB to modulate tumour necrosis factor-induced apoptosis: evidence from mitochondria-targeted antioxidants. Biochem J. 2005;389:83–9.
Cheng G, Zielonka J, McAllister D, Hardy M, Ouari O, Joseph J, et al. Anti proliferative effects of mitochondria-targeted cationic antioxidants and analogs: role of mitochondrial bioenergetics and energy-sensing mechanism. Cancer Lett. 2015;365(1):96–106.
Methner C, Chouchani ET, Buonincontri G, Pell VR, Sawiak SJ, Murphy MP, et al. Mitochondria selective S-nitrosation by mitochondria-targeted S-nitrosothiol protects against post-infarct heart failure in mouse hearts. Eur J Heart Fail. 2014;16:712–7.
Chinta SJ, Kumar M, Hsu M, Rajagopalan S, Kaur D, Rane A. Inducible alterations of glutathione levels in adult dopaminergic midbrain neurons result in nigrostriatal degeneration. J Neurosci. 2007;27:13997–4006.
Terzia A, Irazb M, Sahinc S, Ilhand A, Idize N, Fadilliogluf E. Protective effects of erdosteine on rotenone-induced oxidant injury in liver tissue. Toxicol Ind Health. 2004;20:141–7.
Khurana N, Gajbhiye A. Ameliorative effect of Sida cordifolia in rotenone induced oxidative stress model of Parkinson’s disease. NeuroToxicology. 2013;39:57–64.
Jiang XW, Qiao L, Feng XX, Liu L, Wei QW, Wang XW, et al. Rotenone induces nephrotoxicity in rats: oxidative damage and apoptosis. Toxicol Mech Methods. 2017;27(7):528–36.
Yadav RS, Shukla RK, Sankhwar ML, Patel DK, Ansari RW, Pant AB, et al. Neuroprotective effect of curcumin in arsenic-induced neurotoxicity in rats. NeuroToxicology. 2010;31:533–9.
Parihar P, Jat D, Ghafourifar P, Parihar MS. Effciency of mitochondrially targeted gallic acid in reducing brain mitochondrial oxidative damage. Cell Mol Biol. 2014;60(2):35–41.
Kale A, Pişkin Ö, Baş Y, Aydın BG, Can M, Elmas Ö, et al. Neuroprotective effects of quercetin on radiation-induced brain injury in rats. J Radiat Res. 2018;59(4):404–10.
Kulkarni S, Dhir A, Akula KK. Potentials of curcumin as an antidepressant. Sci World J. 2009;9:1233–41.
Dkhar P, Sharma R. Effect of dimethylsulphoxide and curcumin on protein carbonyls and reactive oxygen species of cerebral hemispheres of mice as a function of age. Int J Dev Neurosci. 2010;28:351–7.
Raza H, John A, Brown EM, Benedict S, Kambal A. Alterations in mitochondrial respiratory functions, redox metabolism and apoptosis by oxidant 4-hydroxynonenal and antioxidants curcumin and melatonin in PC12 cells. Toxicol Appl Pharmacol. 2008;226:161–8.
Nabavi SF, Moghaddam AH, Eslami S, Nabavi SM. Protective effects of curcumin against sodium fluoride-induced toxicity in rat kidneys. Biol Trace Elem Res. 2012;145:369–74.
Garcia-Nino WR, Tapia E, Zazueta C, Zatarain-Barron ZL, Hernandez-Pando R, Vega-Garcia CC, et al. Curcumin pretreatment prevents potassium dichromate-induced hepatotoxicity, oxidative stress, decreased respiratory complex I activity and membrane permeability transition pore opening. Evid Based Complement Alternat Med. 2013;2013:42469243.
Hoek JB, Cahill A, Pastorino JG. Alcohol and mitochondria: a dysfunctional relationship. Gastroenterology. 2002;122:2049–63.
Meister A, Anderson ME. Glutathione. Annu Rev Biochem. 1983;52:711–60.
Acknowledgements
The authors are thankful to the CIL, Dr. Harisingh Gour Vishwavidyalaya (A Central University), Sagar (MP), India for providing instrumentation facilities. Financial support from UGC New-Delhi, India is also acknowledged.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(DOCX 96 kb)
Rights and permissions
About this article
Cite this article
Hasan, W., Kori, R.K., Thakre, K. et al. Synthesis, characterization and efficacy of mitochondrial targeted delivery of TPP-curcumin in rotenone-induced toxicity. DARU J Pharm Sci 27, 557–570 (2019). https://doi.org/10.1007/s40199-019-00283-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40199-019-00283-2